XML 28 R43.htm IDEA: XBRL DOCUMENT v2.4.0.6
Long-term Equity-based Compensation Plans Disclosure of Share-based Compensation Arrangements by Share-based Payment Awards (Details) (USD $)
In Millions, except Share data, unless otherwise specified
9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]    
Options and Stock Appreciation Rights, Outstanding at Beginning of the Year, Number 3,632,398  
Options and Stock Appreciation Rights, Outstanding at Beginning of the Year, Weighted Average Exercise Price $ 40.70  
Options and Stock Appreciation Rights, Grants in Period, Gross 265,451  
Options and Stock Appreciation Rights, Grants in Period, Weighted Average Exercise Price $ 29.81  
Options and Stock Appreciation Rights, Exercises in Period (15,199)  
Options and Stock Appreciation Rights, Exercises in Period, Weighted Average Exercise Price $ 22.08  
Options and Stock Appreciation Rights, Forfeitures and Expirations in Period (452,846)  
Options and Stock Appreciation Rights, Forfeitures and Expirations in Period, Weighted Average Exercise Price $ 48.36  
Options and Stock Appreciation Rights, Outstanding at End of the Year, Number 3,429,804  
Options and Stock Appreciation Rights, Outstanding at End of the Year, Weighted Average Exercise Price $ 38.93  
Options and Stock Appreciation Rights, Outstanding at End of Period, Weighted Average Remaining Contractual Term 4 years 5 months 1 day  
Options and Stock Appreciation Rights, Outstanding at End of Period, Intrinsic Value $ 7.2  
Options and Stock Appreciation Rights, Vested and Expected to Vest, Outstanding at End of Period, Number 3,394,413  
Options and Stock Appreciation Rights, Vested and Expected to Vest, Outstanding at End of Period, Weighted Average Exercise Price $ 39.04  
Options and Stock Appreciation Rights, Vested and Expected to Vest, Outstanding at End of Period, Weighted Average Remaining Contractual Term 4 years 4 months 17 days  
Options and Stock Appreciation Rights, Vested and Expected to Vest, Outstanding at End of Period, Aggregate Intrinsic Value 7.1  
Options and Stock Appreciation Rights, Vested and Expected to Vest, Exercisable at End of Period, Number 2,944,739  
Options and Stock Appreciation Rights, Vested and Expected to Vest, Exercisable at End of Period, Weighted Average Exercise Price $ 40.79  
Options and Stock Appreciation Rights, Vested and Expected to Vest, Exercisable at End of Period, Weighted Average Remaining Contractual Term 3 years 8 months 23 days  
Options and Stock Appreciation Rights, Vested and Expected to Vest, Exercisable at End of Period, Aggregate Intrinsic Value 5.7  
Options, Grants in Period, Weighted Average Grant Date Fair Value $ 9.40 $ 9.11
Options, Exercises in Period, Total Intrinsic Value $ 0.1 $ 0.1